Klimadynon

Dry Extract From Cimicifuga Racemosa (Black Cohosh), the active ingredient in Klimadynon, is a herbal presented as a dry extract for oral use. It is traditionally employed to support women experiencing menopausal and menstrual‑related symptoms. GNH USA supplies Klimadynon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Klimadynon, a black cohosh‑based herbal preparation, is used to address symptoms related to the menopausal transition and associated menstrual discomfort.

- Menopausal vasomotor symptoms: helps reduce the frequency and intensity of hot flashes. - Menstrual discomfort: may alleviate cramping and irregularities during the luteal phase. - Mild mood disturbances: may support emotional balance during hormonal changes.

Adverse reactions reported with black cohosh extracts are generally mild, but monitoring is advised.

Common Side Effects: - Gastrointestinal upset: nausea, abdominal discomfort. - Headache: mild to moderate intensity. - Dizziness: transient light‑headedness. - Skin rash: mild erythema or itching.

Serious or Rare Side Effects: - Hepatic injury: signs of liver dysfunction such as jaundice. - Severe allergic reaction: anaphylaxis with swelling and breathing difficulty. - Thromboembolic events: rare clotting disorders reported. - Cardiovascular events: occasional hypertension or arrhythmia.

When considering Klimadynon, several precautionary measures should be observed.

- Medical history review: assess liver disease, hormone‑sensitive conditions. - Concurrent herbal use: avoid combining with other phytoestrogen products. - Pregnancy and lactation: discontinue unless advised by a physician. - Allergy assessment: check for known hypersensitivity to black cohosh. - Store at ambient temperature below 25 °C: keep in the original container, protect from moisture and direct sunlight.

Potential drug interactions with black cohosh extracts have been identified.

Major Interactions (Avoid): - Hormone replacement therapy: may amplify estrogenic effects, increasing risk of adverse events. - Anticoagulants (e.g., warfarin): possible increased bleeding risk.

Moderate Interactions (Monitor Closely): - Selective serotonin reuptake inhibitors (SSRIs): may affect serotonergic pathways, requiring monitoring. - Cytochrome P450 substrates: black cohosh may alter metabolism of certain drugs, necessitating dose adjustments. - Lithium: potential for altered lithium levels, monitor serum concentrations.